HBK Sorce Advisory’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,924
Closed -$290K 455
2019
Q3
$290K Sell
2,924
-871
-23% -$82.8K 0.03% 332
2019
Q2
$351K Buy
3,795
+130
+4% +$12.3K 0.03% 300
2019
Q1
$346K Sell
3,665
-4,999
-58% -$437K 0.03% 314
2018
Q4
$555K Sell
8,664
-364
-4% -$26.9K 0.06% 205
2018
Q3
$808K Buy
9,028
+1,220
+16% +$108K 0.09% 156
2018
Q2
$620K Sell
7,808
-3,251
-29% -$270K 0.07% 195
2018
Q1
$987K Sell
11,059
-3,622
-25% -$348K 0.12% 121
2017
Q4
$1.53M Buy
14,681
+1,598
+12% +$180K 0.18% 93
2017
Q3
$1.91M Buy
13,083
+69
+0.5% +$9.4K 0.29% 56
2017
Q2
$1.69M Buy
13,014
+144
+1% +$17.6K 0.27% 60
2017
Q1
$1.6M Sell
12,870
-316
-2% -$37.8K 0.27% 56
2016
Q4
$1.53M Sell
13,186
-1,309
-9% -$146K 0.28% 60
2016
Q3
$1.51M Buy
14,495
+518
+4% +$56.1K 0.3% 55
2016
Q2
$1.38M Sell
13,977
-334
-2% -$34.5K 0.3% 57
2016
Q1
$1.43M Buy
14,311
+7,731
+117% +$796K 0.34% 48
2015
Q4
$788K Buy
6,580
+14
+0.2% +$1.62K 0.21% 75
2015
Q3
$710K Sell
6,566
-1,032
-14% -$128K 0.23% 62
2015
Q2
$879K Sell
7,598
-249
-3% -$28.5K 0.3% 54
2015
Q1
$905K Buy
7,847
+764
+11% +$91.3K 0.31% 53
2014
Q4
$792K Buy
7,083
+681
+11% +$71.8K 0.27% 63
2014
Q3
$607K Buy
6,402
+2,344
+58% +$212K 0.22% 69
2014
Q2
$349K Sell
4,058
-60
-1% -$4.56K 0.12% 114
2014
Q1
$287K Hold
4,118
0.1% 130
2013
Q4
$348K Hold
4,118
0.13% 111
2013
Q3
$317K Sell
4,118
-4,118
-50% -$289K 0.13% 112
2013
Q2
$482K Buy
+8,236
New +$496K 0.1% 137

Other funds holding CELG

HBK Sorce Advisory's CELG Position: Q4 2019 in Review

HBK Sorce Advisory sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,924 shares — an estimated $290K sold.

HBK Sorce Advisory first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.91M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • HBK Sorce Advisory reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • HBK Sorce Advisory sold 2,924 Celgene Corp shares in Q4 2019, an estimated $290K.
  • HBK Sorce Advisory first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • HBK Sorce Advisory's Celgene Corp position peaked at $1.91M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on HBK Sorce Advisory's 13F filing for Q4 2019, filed 13 Feb 2020.